Jeremy Whelan
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Seddon B, Dehbi H, Nash S, Forsyth S, Tirabosco R, Küver K, Jamieson D, Veal G, Marples M, Ali N, Benson C, Wood Z, Rothermundt C, Cowie F, Woll P, Leahy M, Whelan J, Strauss S, Beare S. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol 2017
Sep 4, 2017Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Sep 4, 2017Lancet Oncol 2017
Seddon Beatrice, Dehbi Hakim-Moulay, Nash Stephen, Forsyth Sharon, Tirabosco Roberto, Küver Katja, Jamieson David, Veal Gareth J, Marples Maria, Ali Nasim, Benson Charlotte, Wood Zoe, Rothermundt Christian, Cowie Fiona, Woll Penella J, Leahy Michael, Whelan Jeremy, Strauss Sandra J, Beare Sandy
Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas
Whelan J, Khan A, Sharma A, Rothermundt C, Dileo P, Michelagnoli M, Seddon B, Strauss S. Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas. Clin Sarcoma Res 2012; 2:12.
Sep 21, 2012Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas
Sep 21, 2012Clin Sarcoma Res 2012; 2:12
Whelan Jeremy, Khan Atia, Sharma Anand, Rothermundt Christian, Dileo Palma, Michelagnoli Maria, Seddon Beatrice, Strauss Sandra